Dexmedetomidine Hydrochloride In Sodium Chloride Injection, Solution
NDC Package 68094-047-10
Package Information
Dexmedetomidine Hydrochloride In Sodium Chloride (dexmedetomidine hydrochloride) injection is none. This formulation utilizes a injection, solution delivery system. Marketed by Precision Dose, Inc., this product is identified by NDC 68094-047 and is authorized under FDA application ANDA212857.
Identification & Billing
- RxCUI: 1718900 - dexmedeTOMIDine HCl 80 MCG in 20 ML Injection
- RxCUI: 1718900 - 20 ML dexmedetomidine 0.004 MG/ML Injection
- RxCUI: 1718900 - dexmedetomidine (as dexmedetomidine HCl) 80 MCG per 20 ML Injection
- RxCUI: 1718906 - dexmedeTOMIDine HCl 200 MCG in 50 ML Injection
- RxCUI: 1718906 - 50 ML dexmedetomidine 0.004 MG/ML Injection
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 68094 - Precision Dose, Inc.
- 68094-047 - Dexmedetomidine Hydrochloride In Sodium Chloride
- 68094-047-10 - 10 VIAL in 1 CARTON / 20 mL in 1 VIAL (68094-047-01)
- 68094-047 - Dexmedetomidine Hydrochloride In Sodium Chloride
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 68094-047-10 identifies a specific commercial package of 10 vial in 1 carton / 20 ml in 1 vial (68094-047-01) of Dexmedetomidine Hydrochloride In Sodium Chloride, a human prescription drug labeled by Precision Dose, Inc.. This injection, solution is formulated for intravenous use and contains dexmedetomidine hydrochloride as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Precision Dose, Inc. on November 23, 2020. The current certification is valid through December 31, 2026.
How is this Precision Dose, Inc. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 68094004710. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.